Evidence map›Paper›PMID 37332653›Full record

ArticleMovement disorders clinical practice2023

UMSARS Versus Laryngoscopy-Based Assessment of Dysphagia.

Nadia El Fassi, Anne Pavy le Traon, Emmanuelle Mouchon, Olivier Rascol, Wassilios G Meissner, Alexandra Foubert-Saumier, Yohan Gallois, Samuel Tessier, Fabienne Ory-Magne, Virginie A Woisard and 1 more

Open access · hybridAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Movement disorders clinical practice, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.5field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 2 countries.

Nadia El FassiDepartment of ENT Hospital of Larrey Toulouse France.
Anne Pavy le TraonFrench Reference Center for Multiple System Atrophy, Neurology Department Toulouse university hospital and Institute of Metabolic and Cardiovascular Diseases INSERM UMR 1297 Toulouse France.
Emmanuelle MouchonDepartment of ENT Hospital of Larrey Toulouse France.
Olivier RascolClinical Investigation Center CIC1436, Department of Clinical Pharmacology and Neurosciences, Parkinson Expert Centre and NeuroToul Center of Excellence in Neurodegeneration (COEN) of Toulouse INSERM, University of Toulouse 3, CHU of Toulouse Toulouse France.ORCID https://orcid.org/0000-0002-1410-6397
Wassilios G MeissnerCHU Bordeaux, Service de Neurologie des Maladies Neurodégénératives, IMNc Bordeaux France.ORCID https://orcid.org/0000-0003-2172-7527
Alexandra Foubert-SaumierCHU Bordeaux, Service de Neurologie des Maladies Neurodégénératives, IMNc Bordeaux France.
Yohan GalloisDepartment of ENT Hospital of Larrey Toulouse France.
Samuel TessierService de Pharmacologie Médicale et Clinique, Centre de Pharmacovigilance, Faculté de Médecine, de Pharmacoépidémiologie et d'Informations Sur Le Médicament CIC INSERM 1436, Centre Hospitalier Universitaire Toulouse France.
Fabienne Ory-MagneDepartment of Neurology University Hospital of Toulouse Toulouse France.ORCID https://orcid.org/0000-0001-6179-4500
Virginie A WoisardDepartment of ENT Hospital of Larrey Toulouse France.
Margherita FabbriClinical Investigation Center CIC1436, Department of Clinical Pharmacology and Neurosciences, Parkinson Expert Centre and NeuroToul Center of Excellence in Neurodegeneration (COEN) of Toulouse INSERM, University of Toulouse 3, CHU of Toulouse Toulouse France.ORCID https://orcid.org/0000-0001-7250-592X
Hôpital Larrey · FRInserm · FRCentre National de la Recherche Scientifique · FRUniversité Fédérale de Toulouse Midi-Pyrénées · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Multiple System Atrophy (MSA) dysphagia is routinely assessed by the Unified Multiple System Atrophy Rating Scale (UMSARS) part I-item 2. Objective: To compare the UMSARS part I-item 2 with an ear/nose/throat (ENT) expert physician assessment. Methods: We retrospectively analyzed the data of MSA patients who underwent an ENT assessment (nasofibroscopic and radioscopic exam) and an annual UMSARS assessment. Deglutition Handicap Index (DHI) and pulmonary/nutrition complications were collected. Results: Seventy-five MSA patients were included. The ENT assessment revealed more severe dysphagia compared to the UMSARS part I-item 2 score ( Conclusions: The UMSARS-based assessment of dysphagia does not capture key aspects of pharyngo-laryngeal dysfunction reflecting swallowing efficiency.

Indexed as

dysphagiaear nose and throat assessmentmultiple system atrophyUMSARS

Identifiers

PMID37332653
PMCPMC10272892
OpenAlexW4361288363

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.